CERT

Certara Inc

Mar 26 • 04:00PM ET

6.14

+0.04 0.66 %

Healthcare • Health Information Services • USA • NASD

Peers: IQV CRL ICLR CERS MEDP QDEL PDCO HCM XERS

| Held by: IJR VTI VB VBK VXF SPSM DFAT FXH DFSV DFMC

Index	-	P/E	-	EPS (ttm)	-0.01	Insider Own	30.09%	Shs Outstand	159.14M	Perf Week	-3.76%
Market Cap	977.12M	Forward P/E	12.30	EPS next Y	0.50	Insider Trans	0.05%	Shs Float	111.26M	Perf Month	-6.83%
Enterprise Value	1.09B	PEG	1.41	EPS next Q	0.11	Inst Own	88.48%	Short Float	21.38%	Perf Quarter	-31.55%
Income	-1.59M	P/S	2.33	EPS this Y	2.38%	Inst Trans	3.87%	Short Ratio	8.06	Perf Half Y	-46.42%
Sales	418.84M	P/B	0.92	EPS next Y	10.85%	ROA	-0.10%	Short Interest	23.79M	Perf YTD	-30.31%
Book/sh	6.68	P/C	5.16	EPS next 5Y	8.72%	ROE	-0.15%	52W High	15.38 -60.08%	Perf Year	-39.51%
Cash/sh	1.19	P/FCF	10.33	EPS past 3/5Y	- 50.19%	ROIC	-0.12%	52W Low	6.02 1.99%	Perf 3Y	-74.04%
Dividend Est.	-	EV/EBITDA	10.83	Sales past 3/5Y	7.66% 11.45%	Gross Margin	48.03%	Volatility	4.64% 6.01%	Perf 5Y	-78.20%
Dividend TTM	-	EV/Sales	2.61	EPS Y/Y TTM	86.34%	Oper. Margin	6.15%	ATR (14)	0.35	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.05	Sales Y/Y TTM	8.75%	Profit Margin	-0.38%	RSI (14)	33.44	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	2.05	EPS Q/Q	-190.69%	SMA20	-8.19%	Beta	1.60	Target Price	9.11
Payout	-	Debt/Eq	0.29	Sales Q/Q	3.28%	SMA50	-17.91%	Rel Volume	1.34	Prev Close	6.10
Employees	1576	LT Debt/Eq	0.28	Earnings	Feb 26 BMO	SMA200	-37.44%	Avg Volume	2.95M	Price	6.14
IPO	Dec 11, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.50% 0.51%	Trades		Volume	3,959,770	Change	0.66%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Overweight → Equal Weight	$8
Feb-27-26	Downgrade	Craig Hallum	Buy → Hold	$10
Jan-06-26	Upgrade	Leerink Partners	Market Perform → Outperform	$13
Nov-21-25	Initiated	Rothschild & Co Redburn	Buy	$10
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$9
Sep-29-25	Initiated	Craig Hallum	Buy	$16
Jul-03-25	Resumed	Morgan Stanley	Equal-Weight	$16
May-08-25	Upgrade	Barclays	Equal Weight → Overweight	$14
Feb-27-25	Initiated	TD Cowen	Buy	$16
Sep-27-24	Upgrade	UBS	Neutral → Buy	$16
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$23
Apr-04-24	Initiated	JMP Securities	Mkt Perform
Feb-26-24	Initiated	Leerink Partners	Market Perform	$19
Dec-07-23	Initiated	UBS	Neutral	$17
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold	$24.50 → $17
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight	$28
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$17 → $19

Show Previous Ratings

Mar-07-26 11:02PM	Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference (MarketBeat)
Mar-03-26 08:00AM	Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib (GlobeNewswire)
Feb-27-26 08:30AM	Certara, Inc. Q4 2025 Earnings Call Summary (Moby)
08:30AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-26-26 04:08PM	Certara Inc (CERT) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
12:06PM	Loading…
12:06PM	Certara Q4 Earnings Call Highlights (MarketBeat)
08:15AM	Certara, Inc. (CERT) Q4 Earnings Lag Estimates (Zacks)
06:00AM	Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance (GlobeNewswire)
Feb-10-26 02:56PM	Analyst Sentiment on Certara (CERT) Remains Moderately Bullish Despite Sector Volatility (Insider Monkey)
Jan-29-26 08:30AM	Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 (GlobeNewswire)
Jan-27-26 07:38AM	Lower-Than-Expected Service Bookings Impacted Certara (CERT) in Q4 (Insider Monkey)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire)
Dec-11-25 06:00AM	Certara Appoints Jon Resnick as Chief Executive Officer (GlobeNewswire) -5.06%
Dec-09-25 03:33PM	Do Options Traders Know Something About CERT Stock We Don't? (Zacks)
Dec-08-25 12:20PM	Earnings Estimates Moving Higher for Certara (CERT): Time to Buy? (Zacks)
09:55AM	Loading…
09:55AM	Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet (Zacks)
Nov-07-25 12:13AM	Certara Inc (CERT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Booking Challenges (GuruFocus.com) -23.07%
Nov-06-25 06:55PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks)
04:15PM	Certara Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 10:00AM	Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
08:00AM	Certara Automates Scientific Workflows with Phoenix Cloud (GlobeNewswire)
Oct-31-25 08:00AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-30-25 04:15PM	Certara Expands Biosimulation Market with AI-Driven QSP Platform (GlobeNewswire)
10:00AM	Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-20-25 08:00AM	Certara Scientists are Among the Topmost Cited Biopharma Researchers (GlobeNewswire)
Oct-10-25 08:00AM	Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 (GlobeNewswire) -8.35%
Oct-02-25 09:13AM	Can Doximity's New AI Suite Drive the Growth It Needs? (Zacks)
Sep-04-25 08:00AM	Certara Launches Pinnacle 21 Enterprise Plus to Deliver Regulatory Submissions Faster (GlobeNewswire)
Sep-02-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-25 03:28PM	Certara, Inc. (CERT): A Bull Case Theory (Insider Monkey) +18.15%
06:00PM	Loading…
Aug-06-25 06:00PM	Certara, Inc. (CERT) Q2 Earnings Miss Estimates (Zacks)
04:15PM	Certara Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 02:00AM	Certara Simcyp Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling (GlobeNewswire)
Jul-31-25 04:15PM	Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform (GlobeNewswire)
10:00AM	Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-30-25 10:00AM	Certara, Inc. (CERT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-29-25 08:25AM	Alkermes (ALKS) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-18-25 08:38AM	Do Options Traders Know Something About Certara Stock We Don't? (Zacks)
Jul-15-25 01:56PM	Simulations Plus Sees Weaker Demand Persist, Outlook Softens (Benzinga) -6.55%
Jul-11-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-10-25 12:39AM	Morgan Stanley Assumes Coverage of Certara (CERT) Stock (Insider Monkey)
Jul-09-25 04:15PM	Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 (GlobeNewswire)
Jul-08-25 12:05PM	VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait? (Zacks)
08:00AM	Certara Announces Expansion of Clinical Technology Collaboration with Merck (GlobeNewswire)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-20-25 08:25AM	Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS? (Zacks)
May-23-25 09:17AM	AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge (PR Newswire)
May-06-25 08:31AM	Q1 2025 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -11.03%
03:09AM	Certara Inc (CERT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-05-25 07:22PM	Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:45PM	Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	Certara Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
10:01AM	Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-28-25 10:00AM	Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-21-25 08:00AM	3 Momentum Stocks That Could Soar Post-Market Volatility (MarketBeat)
Apr-16-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-15-25 12:40AM	Why Certara Inc. (CERT) Skyrocketed On Monday? (Insider Monkey)
Apr-14-25 08:15AM	Certara Launches Non-Animal Navigator Solution to Help Drug Developers Reduce Reliance on Animal Testing (GlobeNewswire) +11.54%
08:00AM	Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization (GlobeNewswire)
Apr-12-25 06:45PM	Why Certara Inc. (CERT) Soared Last Week? (Insider Monkey)
02:10AM	Why Certara Inc. (CERT) Surged On Friday? (Insider Monkey)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +22.84%
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)
Apr-02-25 12:49PM	Checking Back In On Certara: Unattractive Valuation (Seeking Alpha)
Apr-01-25 08:00AM	Certara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities (GlobeNewswire)
Mar-06-25 07:58PM	Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Mar-05-25 04:15PM	Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions (GlobeNewswire)
Feb-27-25 07:59AM	Q4 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:28AM	Certara Inc (CERT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Feb-26-25 06:45PM	Certara, Inc. (CERT) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Certara Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Feb-14-25 01:12PM	Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey)
Jan-29-25 04:15PM	Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-24-25 12:48PM	Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerinks Target Price Boost to $13 (Insider Monkey)
Jan-15-25 07:55AM	Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) +11.36%
Jan-02-25 04:15PM	Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.16%
Dec-06-24 10:02AM	Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 (Insider Monkey)
Dec-02-24 04:15PM	Certara Showcases 2024 Research Wins With Over 100 Papers Published (GlobeNewswire)
Nov-13-24 09:29AM	Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 (Insider Monkey)
Nov-07-24 10:38AM	Q3 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:27AM	Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-06-24 07:05PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks) +5.82%
04:15PM	Certara Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-28-24 04:15PM	Certara to Participate in the Stephens Annual Investment Conference (GlobeNewswire)
Oct-16-24 04:15PM	Certara Appoints John Reynders as New Independent Board Member (GlobeNewswire)
Oct-15-24 08:05AM	MaxCyte Appoints Cynthia Collins to its Board of Directors (GlobeNewswire)
Oct-09-24 04:15PM	Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 (GlobeNewswire)
Oct-02-24 04:15PM	Certara Completes Acquisition of Chemaxon (GlobeNewswire)
Sep-27-24 07:20PM	Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon (CNBC TV) +9.81%
Sep-24-24 08:00AM	Certara's Simcyp Consortium Celebrates 25th Anniversary (GlobeNewswire)
Sep-18-24 08:00AM	Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug (GlobeNewswire)
Sep-17-24 11:02AM	Should You Increase Your Holdings in Certara (CERT)? (Insider Monkey)
Aug-28-24 07:03PM	Certara, Inc. (CERT): Among The Best Medical AI Companies (Insider Monkey) -5.24%
Aug-21-24 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-15-24 04:15PM	Certara Launches Phoenix Version 8.5 Drug Development Software (GlobeNewswire)
Aug-12-24 03:57AM	Heres Why Certara (CERT) Stock Underperformed in Q2 (Insider Monkey)
Aug-07-24 12:25PM	Q2 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -13.59%
Aug-06-24 06:25PM	Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates (Zacks)
04:15PM	Certara Reports Second Quarter 2024 Financial Results (GlobeNewswire)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feehery William F	CHIEF EXECUTIVE OFFICER	Nov 11 '25	Buy	8.30	24,096	200,000	2,360,769	Nov 12 04:44 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Sep 09 '25	Sale	10.92	51,224	559,366	73,979	Sep 11 04:47 PM
Pedersen Leif E	Officer	Sep 09 '25	Proposed Sale	10.92	51,224	559,304		Sep 09 04:16 PM
Anhalt Rona	Chief Human Resources Officer	May 30 '25	Option Exercise	0.00	7,146	0	7,146	Jun 02 04:58 PM
Corcoran Daniel	SVP and General Counsel	May 30 '25	Option Exercise	0.00	22,828	0	20,530	Jun 02 04:57 PM
WALSH MATTHEW M	Director	May 21 '25	Option Exercise	0.00	11,928	0	197,559	May 22 05:07 PM
Reynders John V W	Director	May 21 '25	Option Exercise	0.00	10,709	0	10,709	May 22 05:05 PM
Killefer Nancy	Director	May 21 '25	Option Exercise	0.00	11,928	0	36,089	May 22 05:04 PM
Crane Rosemary A	Director	May 21 '25	Option Exercise	0.00	11,928	0	29,915	May 22 05:03 PM
Collins Cynthia	Director	May 21 '25	Option Exercise	0.00	11,928	0	36,089	May 22 05:01 PM
CASHMAN JAMES E III	Chairman	May 21 '25	Option Exercise	0.00	11,928	0	468,440	May 22 05:00 PM
BROSHY ERAN	Chairman	May 21 '25	Option Exercise	0.00	11,928	0	34,951	May 22 04:58 PM
Aspbury Robert	PRESIDENT, PREDICTIVE TECH	Apr 01 '25	Option Exercise	0.00	26,626	0	311,936	Apr 03 04:44 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '25	Option Exercise	0.00	26,626	0	127,669	Apr 03 04:40 PM
Gallagher John E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '25	Option Exercise	0.00	42,486	0	51,731	Apr 03 04:36 PM
Feehery William F	CHIEF EXECUTIVE OFFICER	Apr 01 '25	Option Exercise	0.00	111,393	0	2,354,346	Apr 03 04:32 PM
SMITH PATRICK F	Officer	Apr 02 '25	Proposed Sale	9.73	20,142	195,982		Apr 02 10:57 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERT

Certara Inc

Upgrade your FINVIZ experience